发明名称 |
TGF-β signal transduction inhibitor |
摘要 |
The present invention provides a compound represented by the following formula (I) or a physiologically acceptable salt thereof, and use thereof for the prophylaxis or treatment of TGF-β-related diseases:;whereinY is a hydrogen atom and the like;R2 is;and the like;R3 is —NR8—R9— and the like;R4, R5, R6 and R7 are the same or different and each is a hydrogen atom and the like; andX is;and the like. |
申请公布号 |
US8772297(B2) |
申请公布日期 |
2014.07.08 |
申请号 |
US201113579843 |
申请日期 |
2011.02.17 |
申请人 |
Kyoto University |
发明人 |
Kakeya Hideaki;Hattori Akira;Takasu Yasuaki;Fujii Nobutaka;Oishi Shinya;Kojima Soichi;Hara Mitsuko |
分类号 |
A61K31/495;C07D295/104 |
主分类号 |
A61K31/495 |
代理机构 |
Leydig, Voit & Mayer, Ltd. |
代理人 |
Leydig, Voit & Mayer, Ltd. |
主权项 |
1. A compound represented by the following formula (I): wherein Y is a hydrogen atom, a carboxyl group or wherein L is an oxygen atom or a bond, and R1 is optionally substituted C1-6 alkyl; R2 is R3 is —NR8—R9— or a bond, wherein R8 is a hydrogen atom or C1-6 alkyl, and R9 is C1-6 alkylene; R4, R5, R6 and R7 are the same or different and each is a hydrogen atom or C1-6 alkyl; and X is wherein R10 is a hydrogen atom or C1-6 alkyl; and R11 is optionally substituted phenyl, optionally substituted C1-6 alkyl or a hydrogen atom, or R10 and R11 form, together with the nitrogen atom bonded thereto, an optionally substituted 5- to 7-membered cyclic amino group, or a physiologically acceptable salt thereof. |
地址 |
Kyoto JP |